Forward P/S Multiple: AVITA Medical (RCEL)
AVITA Medical, Inc. (RCEL) relies on external component suppliers while managing the final assembly of Recell systems. Growth is driven by the implementation of automation in clinics and new methods for scar treatment. Stable management is confidently steering the company toward net profit. The company's forward P/S dynamics reflect market expectations, with the 5.90 mark indicating the current valuation level of capitalization relative to projected revenue.
Summary analytical data breakdowns for AVITA Medical Inc (RCEL)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital AVITA Medical, Inc.|RCEL - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital AVITA Medical, Inc.|RCEL - Company Aggregate Debts|Debt to Book Capitalization Ratio AVITA Medical Inc|RCEL - Company Long-Term Debt|Company Current Liabilities AVITA Medical|Quick Ratio avitamedical.com
- financial results and valuation multiples details:
RCEL - Company Net Income|Expected Profit AVITA Medical, Inc.|RCEL - Market Cap to Net Income Ratio|Projected Price to Earnings AVITA Medical, Inc|RCEL - PEG Multiple|EV/EBITDA Multiple AVITA Medical Inc|RCEL - Operating income before deduction of amortization|Earnings per share for the last twelve months AVITA Medical|RCEL - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months avitamedical.com|RCEL - Net earnings per share growth this year|Earnings growth forecast for next year AVITA Medical, Inc.
- sales and revenue indicators:
Fundamental company analysis:RCEL (AVITA Medical)
This indicator is calculated as the ratio of the current market value of AVITA Medical, Inc. (RCEL) to projected sales volume, allowing for an assessment of the business value relative to future cash flows. The trend in the expected price-to-sales ratio reflects market optimism as the medical indications for the AVITA Medical system expand, transforming the company's narrow niche specialization into large-scale market potential.
Who AVITA Medical, Inc. competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|profusa.com (PFSA) - Forward P/S Multiple|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Forward P/S Multiple NAOV|Market Cap to Expected Sales Ratio Venus Concept Corporation|Nuwellis, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio AEMD (aethlonmedical.com)|TransEnterix - Forward P/S Multiple|AVGR - Forward P/S Multiple|BSGM (BioSig Technologies, Inc) - Forward Price-to-Revenue Multiple|Cutera Inc - Forward Price to Sales|Price-to-Projected Revenue Ratio Know Labs, Inc.|Forward Price-to-Revenue Multiple inarimedical.com (NARI)|Forward P/S Multiple NVRO|RSLS - Market Cap to Future Revenue Ratio|Forward P/S Multiple SILK (Silk Road Medical Inc.)
